Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 7937814, 8 pages
http://dx.doi.org/10.1155/2016/7937814
Research Article

DNA Damage in CD133-Positive Cells in Barrett’s Esophagus and Esophageal Adenocarcinoma

1Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
2Faculty of Nursing Science, Suzuka University of Medical Science, Suzuka, Mie 513-8670, Japan
3Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan
4Division of Gastroenterology, Tohoku University Hospital, Sendai 980-8574, Japan
5Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie 513-8670, Japan

Received 18 November 2015; Revised 21 January 2016; Accepted 17 February 2016

Academic Editor: Hamid Boulares

Copyright © 2016 Raynoo Thanan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Abdel-Latif, S. Duggan, J. V. Reynolds, and D. Kelleher, “Inflammation and esophageal carcinogenesis,” Current Opinion in Pharmacology, vol. 9, no. 4, pp. 396–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Poehlmann, D. Kuester, P. Malfertheiner, T. Guenther, and A. Roessner, “Inflammation and Barrett's carcinogenesis,” Pathology Research and Practice, vol. 208, no. 5, pp. 269–280, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Cameron, “Barrett's esophagus: does the incidence of adenocarcinoma matter?” The American Journal of Gastroenterology, vol. 92, no. 2, pp. 193–194, 1997. View at Google Scholar · View at Scopus
  4. P. M. Schneider, A. G. Casson, B. Levin et al., “Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases,” Journal of Thoracic and Cardiovascular Surgery, vol. 111, no. 2, pp. 323–333, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kawanishi and Y. Hiraku, “Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation,” Antioxidants and Redox Signaling, vol. 8, no. 5-6, pp. 1047–1058, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, “Oxidative stress, inflammation, and cancer: how are they linked?” Free Radical Biology & Medicine, vol. 49, no. 11, pp. 1603–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Hiraku, “Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance,” Environmental Health and Preventive Medicine, vol. 15, no. 2, pp. 63–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Iijima and T. Shimosegawa, “Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum,” Journal of Gastroenterology and Hepatology, vol. 29, no. 5, pp. 898–905, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Thanan, N. Ma, K. Iijima et al., “Proton pump inhibitors suppress iNOS-dependent DNA damage in Barrett's esophagus by increasing Mn-SOD expression,” Biochemical and Biophysical Research Communications, vol. 421, no. 2, pp. 280–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Cardin, M. Piciocchi, C. Tieppo et al., “Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 Mutation,” Annals of Surgical Oncology, vol. 20, no. 3, pp. S583–S589, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Takaishi, T. Okumura, and T. C. Wang, “Gastric cancer stem cells,” Journal of Clinical Oncology, vol. 26, no. 17, pp. 2876–2882, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. J. Maitland and A. T. Collins, “Inflammation as the primary aetiological agent of human prostate cancer: a stem cell connection?” Journal of Cellular Biochemistry, vol. 105, no. 4, pp. 931–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Ma, R. Thanan, H. Kobayashi et al., “Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection,” Biochemical and Biophysical Research Communications, vol. 414, no. 2, pp. 344–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Thanan, C. Pairojkul, S. Pinlaor et al., “Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis,” Free Radical Biology and Medicine, vol. 65, pp. 1464–1472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Barbera and R. C. Fitzgerald, “Cellular mechanisms of Bsarrett's esophagus development,” Surgical Oncology Clinics of North America, vol. 18, no. 3, pp. 393–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. P. Wild and L. J. Hardie, “Reflux, Barrett's oesophagus and adenocarcinoma: burning questions,” Nature Reviews Cancer, vol. 3, no. 9, pp. 676–684, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Hutchinson, B. Stenstrom, D. Chen et al., “Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant,” Stem Cells and Development, vol. 20, no. 1, pp. 11–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-L. Feng, Y.-Q. Liu, L.-J. Yang et al., “Expression of CD133 correlates with differentiation of human colon cancer cells,” Cancer Biology and Therapy, vol. 9, no. 3, pp. 216–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Immervoll, D. Hoem, P. Sakariassen, O. J. Steffensen, and A. Molven, “Expression of the ‘stem cell marker’ CD133 in pancreas and pancreatic ductal adenocarcinomas,” BMC Cancer, vol. 8, article 48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ishigami, S. Ueno, T. Arigami et al., “Prognostic impact of CD133 expression in gastric carcinoma,” Anticancer Research, vol. 30, no. 6, pp. 2453–2457, 2010. View at Google Scholar · View at Scopus
  22. L. M. Smith, A. Nesterova, M. C. Ryan et al., “CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers,” British Journal of Cancer, vol. 99, no. 1, pp. 100–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Wang, Z.-G. Chen, C.-Z. Du, H.-W. Wang, L. Yan, and J. Gu, “Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer,” Histopathology, vol. 55, no. 3, pp. 284–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Ahmad, K. Arthur, P. Maxwell et al., “A cross sectional study of p504s, CD133, and Twist expression in the esophageal metaplasia dysplasia adenocarcinoma sequence,” Diseases of the Esophagus, vol. 28, no. 3, pp. 276–282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Pinlaor, Y. Hiraku, N. Ma et al., “Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis,” Nitric Oxide, vol. 11, no. 2, pp. 175–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Hiraku and S. Kawanishi, “Immunohistochemical analysis of 8-nitroguanine, a nitrative DNA lesion, in relation to inflammation-associated carcinogenesis,” Methods in Molecular Biology, vol. 512, pp. 3–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Thanan, M. Murata, N. Ma et al., “Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer,” Mediators of Inflammation, vol. 2012, Article ID 165879, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Murata, R. Thanan, N. Ma, and S. Kawanishi, “Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 623019, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Thanan, S. Oikawa, Y. Hiraku et al., “Oxidative stress and its significant roles in neurodegenerative diseases and cancer,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 193–217, 2015. View at Publisher · View at Google Scholar
  30. S. Pinlaor, P. Yongvanit, Y. Hiraku et al., “8-Nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini,” Biochemical and Biophysical Research Communications, vol. 309, no. 3, pp. 567–571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Thanan, M. Murata, S. Pinlaor et al., “Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 3, pp. 518–524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Saichua, A. Yakovleva, C. Kamamia et al., “Levels of 8-OxodG predict hepatobiliary pathology in Opisthorchis viverrini endemic settings in Thailand,” PLoS Neglected Tropical Diseases, vol. 9, no. 7, Article ID e0003949, 2015. View at Publisher · View at Google Scholar
  33. H. Okamoto, F. Fujishima, Y. Nakamura et al., “Significance of CD133 expression in esophageal squamous cell carcinoma,” World Journal of Surgical Oncology, vol. 11, article 51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Tomizawa, T.-T. Wu, and K. K. Wang, “Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from barrett's esophagus,” Oncology Letters, vol. 3, no. 5, pp. 1059–1063, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Li, R. Tamamura, B. Wang et al., “Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma,” BioMed Research International, vol. 2014, Article ID 132349, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Fukamachi, S. Shimada, K. Ito, Y. Ito, and Y. Yuasa, “CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation,” Cancer Science, vol. 102, no. 7, pp. 1313–1321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Hashimoto, K. Aoyagi, T. Isobe, K. Kouhuji, and K. Shirouzu, “Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer,” Gastric Cancer, vol. 17, no. 1, pp. 97–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. M. Li, Y. S. Guo, B. Ma et al., “CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis,” Oncotarget, vol. 6, no. 39, pp. 42019–42027, 2015. View at Publisher · View at Google Scholar
  39. A. Sasaki, T. Kamiyama, H. Yokoo et al., “Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma,” Oncology Reports, vol. 24, no. 2, pp. 537–546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Huang, H. Zhu, J. Feng, S. Ni, and J. Huang, “High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer,” Disease Markers, vol. 2015, Article ID 986095, 8 pages, 2015. View at Publisher · View at Google Scholar
  41. S. Ohnishi, N. Ma, R. Thanan et al., “DNA damage in inflammation-related carcinogenesis and cancer stem cells,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 387014, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus